Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty...

7Park Data Launches Business Spending Intelligence, The First Alternative Data Solution To Offer Visibility Into Business Expenditures Across Sectors NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- 7Park Data, the leading aggregator of alternative data, today announced the launch of Business Spending Intelligence, the industry's first transactional...